Fox Run Management, L.L.C. United Therapeutics Corp Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
A detailed history of Fox Run Management, L.L.C. transactions in United Therapeutics Corp stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 1,216 shares of UTHR stock, worth $374,552. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,216Holding current value
$374,552% of portfolio
0.08%Shares
16 transactions
Others Institutions Holding UTHR
# of Institutions
724Shares Held
58.5MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.64 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.68 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$850 Million14.19% of portfolio
-
State Street Corp Boston, MA2.2MShares$678 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...